Corcept Therapeutics
CORT
#1762
Rank
NZ$21.15 B
Marketcap
NZ$195.71
Share price
0.89%
Change (1 day)
62.84%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.75

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.79. In 2025 the company made an earnings per share (EPS) of NZ$1.65 a decrease over its 2024 EPS that were of NZ$2.36.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.75-54.7%
2025NZ$1.65-30.37%
2024NZ$2.36
2022NZ$1.66-2.06%
2021NZ$1.705.43%
2020NZ$1.6110.84%
2019NZ$1.4527.69%
2018NZ$1.14-42.48%
2017NZ$1.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.29 1,841.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.29 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.41 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.26 694.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.23 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.12-115.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03501-104.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.45 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA